OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Public Statements

Office

Presidential Congressional Gubernatorial State Legislative Federal Judicial Statewide State Judicial

State

Alabama Alaska American Samoa Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana National Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Northern Mariana Islands Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming

Issue

All Issues Abortion Agriculture and Food Animals and Wildlife Arts, Entertainment, and History Business and Consumers Campaign Finance Civil Liberties and Civil Rights Constitution Criminal Justice Death Penalty Defense Drugs Economy and Fiscal Education Elections Employment and Affirmative Action Energy Entitlements and the Safety Net Environment Executive Branch Family Federal, State and Local Relations Finance and Banking Food Processing and Sales Foreign Affairs Foreign Aid Gambling and Gaming Government Budget and Spending Government Operations Guns Health Insurance Health and Health Care Higher Education Housing and Property Immigration Indigenous Peoples Infrastructure Judicial Branch K-12 Education Labor Unions Legal Legislative Branch Marijuana Marriage Military Personnel Minors and Children Monetary Policy National Security Natural Resources Oil and Gas Religion Reproduction Science Senior Citizens Sexual Orientation and Gender Identity Stem Cell Research Taxes Technology and Communication Trade Transportation Unemployed and Low-Income Veterans Women

Limit results to:

Date Range

Keyword Search

Search string must be longer than 3 characters.
Page 1 of 18
results per page:
75 50 25
Date Title Politician
Oct. 19, 2023 Thune, Hassan, Blackburn Introduce the SAVE IMD Options Act Sen. Maggie Hassan
Nov. 4, 2022 Following Push from Senator Hassan, Administration Expands Opioid Treatment Options By Telehealth Sen. Maggie Hassan
Sept. 19, 2022 Kuster, Miller-Meeks, Murphy, and Barragán Introduce Bipartisan Bill to Lower Drug Prices, Expedite Substitution Process for Pharmaceuticals Rep. Annie Kuster
Sept. 13, 2022 Senators Baldwin, Shaheen Introduce Legislation to Give Local and Tribal Communities Tools to Combat the Opioid and Substance Use Disorder Epidemic Sen. Jeanne Shaheen, ...
July 26, 2022 Senator Hassan Pushes to Address Fentanyl Overdoses & Substance Misuse During Senate Hearing Sen. Maggie Hassan
July 25, 2022 Letter to Hon. Robert M. Califf, Commissioner of the FDA - Senator Baldwin Voices Support for FDA's Proposed "Life-Saving" Ban on Menthol Cigarettes and Flavored Cigars Sen. Maggie Hassan, ...
July 21, 2022 Letter to Robert Califf, Commissioner of the Food and Drug Administration - Senators Hassan and Paul Press FDA to Increase Access to Life-Saving Naloxone Sen. Maggie Hassan, ...
June 29, 2022 Shaheen Statement on New DOJ Initiative to Combat Substance Use Disorder Epidemic in New England Sen. Jeanne Shaheen
June 9, 2022 NEW: Shaheen Ushers Numerous National Security Measures through Senate Foreign Relations Committee Sen. Jeanne Shaheen
June 8, 2022 Bipartisan Addiction and Mental Health Task Force Hosts Roundtable with ONDCP Director Rep. Annie Kuster
May 20, 2022 Shaheen, Hassan & Pappas Participate in Roundtable Discussion on Substance Use Prevention and Treatment Efforts with ONDCP Director Gupta Sen. Jeanne Shaheen
May 19, 2022 NH Delegation Welcomes More Than $28M to Combat Opioid Crisis Through SOR Grant Funding Rep. Chris Pappas
May 19, 2022 NH Delegation Welcomes More Than $28M to Combat Opioid Crisis Through SOR Grant Funding Sen. Jeanne Shaheen
May 19, 2022 NH Delegation Welcomes More Than $28M to Combat Opioid Crisis Through SOR Grant Funding ? Rep. Annie Kuster
May 10, 2022 Pappas Statement on National Fentanyl Awareness Day Rep. Chris Pappas
May 9, 2022 Pappas, Bacon, Lead Bipartisan Call for HHS to Update Opioid PHE Declaration to Include Methamphetamines Rep. Chris Pappas
May 6, 2022 Feinstein, Grassley, Colleagues Seek to Deter Counterfeit Pill Production Sen. Maggie Hassan, ...
April 29, 2022 Shaheen Encourages Granite Staters to Participate in Drug Take Back Day Sen. Jeanne Shaheen
April 28, 2022 Pappas, Salazar, Lead Bipartisan Call for DHS to Adopt Common Operating Platform to Bolster Anti-Trafficking Efforts Rep. Chris Pappas
April 21, 2022 Kuster Statement on Priorities of ONDCP, Emphasizes Importance of Reducing Demand and Interrupting Supply of Illicit Drugs Rep. Annie Kuster
April 12, 2022 Senator Shaheen, Hassan Join Push to Make Naloxone Available Over the Counter Sen. Jeanne Shaheen
April 11, 2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter Sen. Maggie Hassan, ...
April 1, 2022 Pappas Statement on MORE Act Vote Rep. Chris Pappas
March 31, 2022 Congressmen Gonzales and Pappas Introduce Bipartisan Legislation to Stop Trafficking of Illegal Drugs Through the Dark Web Rep. Chris Pappas, ...
March 30, 2022 Pappas Urges Adoption for Amendment to Close MORE Act Loopholes for Drug Traffickers and Violent Felons Rep. Chris Pappas
March 30, 2022 Pappas and Gonzales Introduce Bipartisan Legislation to Stop Trafficking of Illegal Drugs Through the Dark Web Rep. Chris Pappas
March 30, 2022 Reps. Pappas, Axne, Buschon, and Miller-Meeks Introduce Bill to Expand Access to Opioid Use Disorder Treatment Rep. Chris Pappas
March 28, 2022 Shaheen & Rep. Gottheimer Lead Bicameral Legislation to Prevent Opioid Misuse Among Students and Student Athletes Sen. Jeanne Shaheen
March 16, 2022 Schakowsky, Warren, Klobuchar, Porter, Colleagues Call Out Drug Manufacturers For Providing Misleading Information on High Drug Prices Sen. Maggie Hassan, ...
March 14, 2022 Kuster, Pappas Question Law Enforcement on Evolving Addiction Crisis in New Hampshire Rep. Annie Kuster
March 10, 2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay Sen. Jeanne Shaheen, ...
March 10, 2022 Senators Shaheen, Capito, Reps. McKinley, Thompson Introduce Bipartisan Access to Prescription Digital Therapeutics Act Sen. Jeanne Shaheen
March 7, 2022 Ahead of March 11 Temporary Scheduling Expiration Date, Pappas, Newhouse, and Budd to Introduce Bipartisan Save Americans from the Fentanyl Emergency Act of 2022 Rep. Chris Pappas, ...
March 1, 2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs Sen. Maggie Hassan, ...
Feb. 25, 2022 Letter to Chuck Schumer, Senate Majority Leader, Patrick Leahy, Chair of the Senate Appropriations Committee, Chris Murphy, Chair of the Senate Subcommittee on Homeland Security - Peters Calls for Robust Funding to Support DHS Border Security and Drug Detection Sen. Maggie Hassan, ...
Feb. 16, 2022 Senator Hassan, Colleagues Urge DOJ to Investigate Sackler Family Members for Role in Fueling Substance Misuse Crisis Sen. Maggie Hassan
Feb. 16, 2022 Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC Sen. Maggie Hassan, ...
Feb. 15, 2022 Senator Hassan Votes Against Confirming FDA Commissioner Nominee, Robert Califf Sen. Maggie Hassan
Feb. 8, 2022 Pappas Votes to Prevent Government Shutdown, Reiterates Call to Pass Full Appropriations Bill for FY 2022 Rep. Chris Pappas
Feb. 1, 2022 Pappas Reiterates Call for Congressional Action to Lower Prescription Drug Prices Rep. Chris Pappas
Jan. 26, 2022 McBath Joins Colleagues to Introduce Bipartisan Bill to Prevent Substance Abuse Among Students Rep. Chris Pappas, ...
Jan. 12, 2022 Pappas, Buchanan Lead Bipartisan Call to Stop Fentanyl Trafficking Rep. Chris Pappas
Dec. 21, 2021 NH Delegation Welcomes $4.7 Million to Support Individuals & Families Impacted by Substance Use Disorders Rep. Chris Pappas, ...
Dec. 21, 2021 Van Hollen, Warren, Baldwin, Maloney Reintroduce Landmark CARE Act to Combat the Substance Use Epidemic Rep. Annie Kuster, ...
Dec. 20, 2021 NH Delegation Welcomes $1.6 Million to Combat Substance Use Disorder Crisis through NH Drug Court Program Sen. Maggie Hassan, ...
Dec. 16, 2021 Baldwin, Warren, Maloney Lead More than 100 Democrats in Senate and House in Reintroducing Landmark CARE Act to Combat the Substance Use Epidemic Rep. Annie Kuster, ...
Dec. 14, 2021 Kuster Applauds Announcement of $30 Million Funding Opportunity to Help Address the Substance Use and Overdose Epidemic Through Harm Reduction Rep. Annie Kuster
Dec. 2, 2021 Kuster Urges Passage of Her Bipartisan STOP Fentanyl Act During Energy & Commerce Hearing Rep. Annie Kuster
Nov. 17, 2021 Bipartisan Addiction and Mental Health Task Force Statement on U.S. Drug Overdose Deaths Surpassing 100,000 in 12-Month Period Rep. Annie Kuster
Nov. 2, 2021 Following Pappas's Advocacy, Deal Announced to Include Prescription Drug Pricing Reforms in Build Back Better Legislation Rep. Chris Pappas
Date Title Politician
Oct. 19, 2023 Thune, Hassan, Blackburn Introduce the SAVE IMD Options Act Sen.Maggie Hassan
Nov. 4, 2022 Following Push from Senator Hassan, Administration Expands Opioid Treatment Options By Telehealth Sen.Maggie Hassan
Sept. 19, 2022 Kuster, Miller-Meeks, Murphy, and Barragán Introduce Bipartisan Bill to Lower Drug Prices, Expedite Substitution Process for Pharmaceuticals Rep.Annie Kuster
Sept. 13, 2022 Senators Baldwin, Shaheen Introduce Legislation to Give Local and Tribal Communities Tools to Combat the Opioid and Substance Use Disorder Epidemic Sen.Jeanne Shaheen, ...
July 26, 2022 Senator Hassan Pushes to Address Fentanyl Overdoses & Substance Misuse During Senate Hearing Sen.Maggie Hassan
July 25, 2022 Letter to Hon. Robert M. Califf, Commissioner of the FDA - Senator Baldwin Voices Support for FDA's Proposed "Life-Saving" Ban on Menthol Cigarettes and Flavored Cigars Sen.Maggie Hassan, ...
July 21, 2022 Letter to Robert Califf, Commissioner of the Food and Drug Administration - Senators Hassan and Paul Press FDA to Increase Access to Life-Saving Naloxone Sen.Maggie Hassan, ...
June 29, 2022 Shaheen Statement on New DOJ Initiative to Combat Substance Use Disorder Epidemic in New England Sen.Jeanne Shaheen
June 9, 2022 NEW: Shaheen Ushers Numerous National Security Measures through Senate Foreign Relations Committee Sen.Jeanne Shaheen
June 8, 2022 Bipartisan Addiction and Mental Health Task Force Hosts Roundtable with ONDCP Director Rep.Annie Kuster
May 20, 2022 Shaheen, Hassan & Pappas Participate in Roundtable Discussion on Substance Use Prevention and Treatment Efforts with ONDCP Director Gupta Sen.Jeanne Shaheen
May 19, 2022 NH Delegation Welcomes More Than $28M to Combat Opioid Crisis Through SOR Grant Funding Rep.Chris Pappas
May 19, 2022 NH Delegation Welcomes More Than $28M to Combat Opioid Crisis Through SOR Grant Funding Sen.Jeanne Shaheen
May 19, 2022 NH Delegation Welcomes More Than $28M to Combat Opioid Crisis Through SOR Grant Funding ? Rep.Annie Kuster
May 10, 2022 Pappas Statement on National Fentanyl Awareness Day Rep.Chris Pappas
May 9, 2022 Pappas, Bacon, Lead Bipartisan Call for HHS to Update Opioid PHE Declaration to Include Methamphetamines Rep.Chris Pappas
May 6, 2022 Feinstein, Grassley, Colleagues Seek to Deter Counterfeit Pill Production Sen.Maggie Hassan, ...
April 29, 2022 Shaheen Encourages Granite Staters to Participate in Drug Take Back Day Sen.Jeanne Shaheen
April 28, 2022 Pappas, Salazar, Lead Bipartisan Call for DHS to Adopt Common Operating Platform to Bolster Anti-Trafficking Efforts Rep.Chris Pappas
April 21, 2022 Kuster Statement on Priorities of ONDCP, Emphasizes Importance of Reducing Demand and Interrupting Supply of Illicit Drugs Rep.Annie Kuster
April 12, 2022 Senator Shaheen, Hassan Join Push to Make Naloxone Available Over the Counter Sen.Jeanne Shaheen
April 11, 2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter Sen.Maggie Hassan, ...
April 1, 2022 Pappas Statement on MORE Act Vote Rep.Chris Pappas
March 31, 2022 Congressmen Gonzales and Pappas Introduce Bipartisan Legislation to Stop Trafficking of Illegal Drugs Through the Dark Web Rep.Chris Pappas, ...
March 30, 2022 Pappas Urges Adoption for Amendment to Close MORE Act Loopholes for Drug Traffickers and Violent Felons Rep.Chris Pappas
March 30, 2022 Pappas and Gonzales Introduce Bipartisan Legislation to Stop Trafficking of Illegal Drugs Through the Dark Web Rep.Chris Pappas
March 30, 2022 Reps. Pappas, Axne, Buschon, and Miller-Meeks Introduce Bill to Expand Access to Opioid Use Disorder Treatment Rep.Chris Pappas
March 28, 2022 Shaheen & Rep. Gottheimer Lead Bicameral Legislation to Prevent Opioid Misuse Among Students and Student Athletes Sen.Jeanne Shaheen
March 16, 2022 Schakowsky, Warren, Klobuchar, Porter, Colleagues Call Out Drug Manufacturers For Providing Misleading Information on High Drug Prices Sen.Maggie Hassan, ...
March 14, 2022 Kuster, Pappas Question Law Enforcement on Evolving Addiction Crisis in New Hampshire Rep.Annie Kuster
March 10, 2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay Sen.Jeanne Shaheen, ...
March 10, 2022 Senators Shaheen, Capito, Reps. McKinley, Thompson Introduce Bipartisan Access to Prescription Digital Therapeutics Act Sen.Jeanne Shaheen
March 7, 2022 Ahead of March 11 Temporary Scheduling Expiration Date, Pappas, Newhouse, and Budd to Introduce Bipartisan Save Americans from the Fentanyl Emergency Act of 2022 Rep.Chris Pappas, ...
March 1, 2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs Sen.Maggie Hassan, ...
Feb. 25, 2022 Letter to Chuck Schumer, Senate Majority Leader, Patrick Leahy, Chair of the Senate Appropriations Committee, Chris Murphy, Chair of the Senate Subcommittee on Homeland Security - Peters Calls for Robust Funding to Support DHS Border Security and Drug Detection Sen.Maggie Hassan, ...
Feb. 16, 2022 Senator Hassan, Colleagues Urge DOJ to Investigate Sackler Family Members for Role in Fueling Substance Misuse Crisis Sen.Maggie Hassan
Feb. 16, 2022 Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC Sen.Maggie Hassan, ...
Feb. 15, 2022 Senator Hassan Votes Against Confirming FDA Commissioner Nominee, Robert Califf Sen.Maggie Hassan
Feb. 8, 2022 Pappas Votes to Prevent Government Shutdown, Reiterates Call to Pass Full Appropriations Bill for FY 2022 Rep.Chris Pappas
Feb. 1, 2022 Pappas Reiterates Call for Congressional Action to Lower Prescription Drug Prices Rep.Chris Pappas
Jan. 26, 2022 McBath Joins Colleagues to Introduce Bipartisan Bill to Prevent Substance Abuse Among Students Rep.Chris Pappas, ...
Jan. 12, 2022 Pappas, Buchanan Lead Bipartisan Call to Stop Fentanyl Trafficking Rep.Chris Pappas
Dec. 21, 2021 NH Delegation Welcomes $4.7 Million to Support Individuals & Families Impacted by Substance Use Disorders Rep.Chris Pappas, ...
Dec. 21, 2021 Van Hollen, Warren, Baldwin, Maloney Reintroduce Landmark CARE Act to Combat the Substance Use Epidemic Rep.Annie Kuster, ...
Dec. 20, 2021 NH Delegation Welcomes $1.6 Million to Combat Substance Use Disorder Crisis through NH Drug Court Program Sen.Maggie Hassan, ...
Dec. 16, 2021 Baldwin, Warren, Maloney Lead More than 100 Democrats in Senate and House in Reintroducing Landmark CARE Act to Combat the Substance Use Epidemic Rep.Annie Kuster, ...
Dec. 14, 2021 Kuster Applauds Announcement of $30 Million Funding Opportunity to Help Address the Substance Use and Overdose Epidemic Through Harm Reduction Rep.Annie Kuster
Dec. 2, 2021 Kuster Urges Passage of Her Bipartisan STOP Fentanyl Act During Energy & Commerce Hearing Rep.Annie Kuster
Nov. 17, 2021 Bipartisan Addiction and Mental Health Task Force Statement on U.S. Drug Overdose Deaths Surpassing 100,000 in 12-Month Period Rep.Annie Kuster
Nov. 2, 2021 Following Pappas's Advocacy, Deal Announced to Include Prescription Drug Pricing Reforms in Build Back Better Legislation Rep.Chris Pappas
Page 1 of 18
arrow_upward